BioPharma Dive May 13, 2019
Pharmaceutical companies amass troves of data. But for most large drugmakers, the executives in charge of those data stores don’t make the C-suite.
Only seven of the nearly 30 pharma and biotech companies valued at more than $10 billion rank a chief digital or information officer alongside their heads of science and research on their executive committees.
Six of those individuals, however, were appointed to top management within the last two years — a shift that comes as tech companies like Amazon and Apple inch further into medicine.
Such placements afford greater influence for organization-wide changes, industry watchers say, and signal drugmakers are taking seriously the potential of digital technologies to change how they do business. For some companies, the...
Today's Sponsors
Today's Sponsor